BOEHRINGER INGELHEIM FLOMAX APPROVAL MAKES PRODUCT THIRD ALPHA BLOCKER FOR BPH; LONG-TERM EUROPEAN/U.S. DATA SHOW CONTINUED EFFICACY IN BPH SYMPTOMS